BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7616006)

  • 1. Lymphocyte activation in cutaneous drug reactions.
    Hertl M; Merk HF
    J Invest Dermatol; 1995 Jul; 105(1 Suppl):95S-98S. PubMed ID: 7616006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominance of epidermal CD8+ T lymphocytes in bullous cutaneous reactions caused by beta-lactam antibiotics.
    Hertl M; Bohlen H; Jugert F; Boecker C; Knaup R; Merk HF
    J Invest Dermatol; 1993 Dec; 101(6):794-9. PubMed ID: 8245507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+ dermal T cells from a sulphamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes.
    Hertl M; Jugert F; Merk HF
    Br J Dermatol; 1995 Feb; 132(2):215-20. PubMed ID: 7534104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced exanthems.
    Yawalkar N
    Toxicology; 2005 Apr; 209(2):131-4. PubMed ID: 15767025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bullous drug reactions].
    Hertl-Yazdi MS; Hertl M
    Hautarzt; 2005 Jan; 56(1):16-23. PubMed ID: 15625601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunological and clinical spectrum of delayed drug-induced exanthems.
    Lerch M; Pichler WJ
    Curr Opin Allergy Clin Immunol; 2004 Oct; 4(5):411-9. PubMed ID: 15349041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell involvement in cutaneous drug eruptions.
    Hari Y; Frutig-Schnyder K; Hurni M; Yawalkar N; Zanni MP; Schnyder B; Kappeler A; von Greyerz S; Braathen LR; Pichler WJ
    Clin Exp Allergy; 2001 Sep; 31(9):1398-408. PubMed ID: 11591190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular pathophysiology of cutaneous drug reactions.
    Pichler WJ; Yawalkar N; Britschgi M; Depta J; Strasser I; Schmid S; Kuechler P; Naisbitt D
    Am J Clin Dermatol; 2002; 3(4):229-38. PubMed ID: 12010068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis.
    Echchakir H; Bagot M; Dorothée G; Martinvalet D; Le Gouvello S; Boumsell L; Chouaib S; Bensussan A; Mami-Chouaib F
    J Invest Dermatol; 2000 Jul; 115(1):74-80. PubMed ID: 10886511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of drug-specific T cells in phenobarbital-induced eruption.
    Hashizume H; Takigawa M; Tokura Y
    J Immunol; 2002 May; 168(10):5359-68. PubMed ID: 11994495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective generation of CD8+ T-cell clones from the peripheral blood of patients with cutaneous reactions to beta-lactam antibiotics.
    Hertl M; Geisel J; Boecker C; Merk HF
    Br J Dermatol; 1993 Jun; 128(6):619-26. PubMed ID: 8338745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells isolated from positive epicutaneous test reactions to amoxicillin and ceftriaxone are drug specific and cytotoxic.
    Yawalkar N; Hari Y; Frutig K; Egli F; Wendland T; Braathen LR; Pichler WJ
    J Invest Dermatol; 2000 Oct; 115(4):647-52. PubMed ID: 10998137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic mechanisms in different forms of T-cell-mediated drug allergies.
    Kuechler PC; Britschgi M; Schmid S; Hari Y; Grabscheid B; Pichler WJ
    Allergy; 2004 Jun; 59(6):613-22. PubMed ID: 15147446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity.
    Hanafusa T; Azukizawa H; Matsumura S; Katayama I
    J Dermatol Sci; 2012 Mar; 65(3):213-9. PubMed ID: 22226608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes.
    Traidl C; Sebastiani S; Albanesi C; Merk HF; Puddu P; Girolomoni G; Cavani A
    J Immunol; 2000 Sep; 165(6):3058-64. PubMed ID: 10975816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC-dependent and -independent activation of human nickel-specific CD8+ cytotoxic T cells from allergic donors.
    Moulon C; Wild D; Dormoy A; Weltzien HU
    J Invest Dermatol; 1998 Sep; 111(3):360-6. PubMed ID: 9740224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
    Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous T-cell lymphoma lesional epidermal cells activate autologous CD4+ T lymphocytes: involvement of both CD1+OKM5+ and CD1+OKM5- antigen-presenting cells.
    Hansen ER; Baadsgaard O; Lisby S; Cooper KD; Thomsen K; Vejlsgaard GL
    J Invest Dermatol; 1990 Apr; 94(4):485-91. PubMed ID: 1968933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine.
    Mauri-Hellweg D; Bettens F; Mauri D; Brander C; Hunziker T; Pichler WJ
    J Immunol; 1995 Jul; 155(1):462-72. PubMed ID: 7602118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High IL-5 production by human drug-specific T cell clones.
    Pichler WJ; Zanni M; von Greyerz S; Schnyder B; Mauri-Hellweg D; Wendland T
    Int Arch Allergy Immunol; 1997; 113(1-3):177-80. PubMed ID: 9130515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.